Found: 4
Select item for more details and to access through your institution.
Diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer.
- Published in:
- World Journal of Surgical Oncology, 2017, v. 15, p. 1, doi. 10.1186/s12957-017-1117-4
- By:
- Publication type:
- Article
Detection Rate of <sup>18</sup>F-choline-PET/CT and <sup>68</sup>Ga-PSMA-HBED-CCPET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220541
- By:
- Publication type:
- Article
Detection Rate of <sup>18</sup>F-Choline PET/CT and <sup>68</sup>Ga-PSMAHBED- CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 971, doi. 10.2967/jnumed.118.220541
- By:
- Publication type:
- Article
Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only.
- Published in:
- Strahlentherapie und Onkologie, 2015, v. 191, n. 4, p. 310, doi. 10.1007/s00066-014-0763-5
- By:
- Publication type:
- Article